Physician profile
Robert Bookman
NPI 1164953121
$448.42
in general payments reported to CMS, 2019-2025
10 companies · $204 in 2025
The $204 reported for 2025 was more than what 76% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.18 · 2021: $101 · 2022: $43.26 · 2023: $37.31 · 2024: $47.71 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $147.26 | 2021-2025 | Collagenase Santyl |
| Pfizer INC. | $125.59 | 2020-2023 | |
| Urgo Medical North America, LLC | $42.07 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organogenesis INC. | $26.40 | 2025 | Puraply Wound Matrix |
| Lifenet Health | $26.07 | 2025 | Theragenesis Wound Matrix |
| Cashflow Solutions, LLC | $19.77 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Astrazeneca Pharmaceuticals LP | $19.65 | 2022 | |
| Solventum Corporation | $17.20 | 2025 | Activ.A.C. |
| Hydrofera LLC | $13.29 | 2024 | Hydrofera Blue |
| Biowound Solutions, INC. | $11.12 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bookman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.